Summary
NEW YORK (HedgeWorld.com) - ImClone Systems Inc., the biomedical concern whose stock moves played a part in the prosecution of Martha Stewart, has reached an agreement with its second-largest shareholder, Carl Icahn, about the composition of its board of directors.
The management slate for the upcoming annual meeting will include Mr. Icahn, two non-incumbent associates of his (Charles Woler, Richard Mulligan) and an incumbent member of the board who recently has become an employee of an entity of Mr. Icahn's, Alex Denner.See the full content of this document
Extract
Imclone Deals with Icahn & Fischer
During settlement discussions, Mr. Icahn stressed to the chairman of the board of I...
See the full content of this document
Sponsored links
